Pillole.org - Capitoli: Ulcera peptica

Capitoli

	Menu
	Home Capitoli Avvisi Cerca Indice Introduzione Propedesi Diagnosi Oncologia Cardiovascolare Metabolismo Pneumologia Ematologia Endocrinologia Neurologia Psichiatria Muscoloscheletrico Gastrointestinale Epatologia Salute donna Urologia Miscellanea Medicina legale Casi Clinici

Ulcera peptica

pag 19

BIBLIOGRAFIA

1. Gutthann SP et al. Individual nonsteroidal anti-inflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 1997; 8: 18-24.
2. Piper JM et al. Corticosteroid use and peptic ulcer disease: role of nonsteroidal
anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-740.
3. http://www.ospedaleniguarda.it/resources/Gastroprotezione_534.pdf
4. Soll A et al. Consensus conference. Medical Treatment of peptic ulcer disease. JAMA 1996; 275:622-29
5. Chan FKL et al. Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding. N Engl J Med 2005 Jan 20; 352:238-244
6. Ford A et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. The Cochrane Database of Systematic Reviews 2003,Issue 4.
7.Gisbert JP et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. The Cochrane Database of Systematic Reviews 2004, Issue 2.
8. Leontiadis G I et al. Proton pump inhibitor treatment for acute peptic ulcer bleeding. The Cochrane Database of Systematic Reviews 2004, Issue 3.
9. Rostom A et al. Prevention of NSAID-induced gastroduodenal ulcers. The Cochrane Database of Systematic Reviews 2002, Issue 4.
10.Serrano P et al. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002 Nov; 16:1945-53.
11. Chen-Chiung Liu et al. Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer. A 5-Year Prospective, Randomized, Controlled Study. Arch Intern Med. 2003 Sept 22; 163:2020-2024)
12.Leontitidas GI et al. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ 2005 Mar 12; 330:568
13. Hooper L et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs : systematic review. BMJ 2004; 329:948-952.
14. Hippisley – Cox et al. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs : population based nested case-control analysis. BMJ 2005 Dec 3; 331:1310-1316.
15. Sing G et al. Celecoxib Versus Naproxen and Diclofenac in Osteoarthritis Patients: SUCCESS-I Study .Am J Med. 2006 March;119:255-266
16. White WB, Borer JS, Gorelick PB, et al. Cardiovascular events in clinical trials involving over 41,000 patients evaluating the cyclooxygenase-2 inhibitor celecoxib. American College of Cardiology 2006 Scientific Sessions; March 11-14, 2006; Atlanta, GA.
17. Beasley R et al. R Soc Med 2006; 99:132-40
18. Singh G, Mithal A, Triadafilopoulos G. Both selective COX-2 inhibitors and non-selective NSAIDs increase the risk of acute myocardial infarction in patients with arthritis: Selectivity is with the patient, not the drug class. EULAR 2005; June 8-11, 2005; Vienna, Austria. OP0091.
19. Efficacia e sicurezza dei FANS tradizionali e dei Coxib, 24-03-2006; Università Cattolica Del Sacro Cuore; Roma
20. Jonhsen SP et al. Risk of Hospitalization for Myocardial Infarction Among Users of Rofecoxib, Celecoxib, and Other NSAIDs . A Population-Based Case-Control Study . Arch Intern Med. 2005 May 9; 165:978-984.
21. Circulation. 2006;113:1578-1587.
22. Cannon Cp et al. for the MEDAL Steering Committee. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2006 Nov 18; 368:1771-1781
23. Rostom A e tal. Prevention of NSAID-induced gastroduodenal ulcers. The Cochrane Database of Systematic Reviews 2006 Issue 4
24. Lanas A et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006 Dec;55:1731-1738.

<< pag 18

2004 - 2024 © Pillole.org Reg. T. di Roma 2/06 |

ore 09:39 | 1286405 accessi| utenti in linea: 45775

Realizzato con ASP-Nuke 2.0.5